Rgs2 mediates pro-angiogenic function of Myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Boelte, Kimberly C ^a   Gordy, Laura E ^a   Joyce, Sebastian ^a   Thompson, Mary Ann ^b   Yang, Li ^c   Lin, P Charles ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; RGS2 PROTEIN; CCL2 PROTEIN, MOUSE; RGS PROTEIN; RGS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYPOXIA; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UPREGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL DEATH; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

MUS;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL2; ENDOTHELIAL CELLS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED C57BL; MYELOID CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RGS PROTEINS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 79954471164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018534     Document Type: Article

References (33)

1. Tlsty TD, Coussens LM, (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
2. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
3. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S, (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179: 977-983.
4. Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, et al. (2004) Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409-421.
5. Shojaei F, Wu X, Zhong C, Yu L, Liang XH, et al. (2007) Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450: 825-831.
6. Yang L, Huang J, Ren X, Gorska AE, Chytil A, et al. (2008) Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13: 23-35.
7. Murdoch C, Muthana M, Coffelt SB, Lewis CE, (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618-631.
8. Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, et al. (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 25: 911-920.
9. Druey KM, Blumer KJ, Kang VH, Kehrl JH, (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379: 742-746.
10. Koelle MR, Horvitz HR, (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 84: 115-125.
11. Siderovski DP, Hessel A, Chung S, Mak TW, Tyers M, (1996) A new family of regulators of G-protein-coupled receptors? Curr Biol 6: 211-212.
12. Reif K, Cyster JG, (2000) RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 164: 4720-4729.
13. Shi GX, Harrison K, Han SB, Moratz C, Kehrl JH, (2004) Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J Immunol 172: 5175-5184.
14. De Vries L, Zheng B, Fischer T, Elenko E, Farquhar MG, (2000) The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40: 235-271.
15. Ross EM, Wilkie TM, (2000) GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69: 795-827.
16. Zmijewski JW, Song L, Harkins L, Cobbs CS, Jope RS, (2001) Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys 392: 192-196.
17. Song L, Jope RS, (2006) Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cells. Neurosci Lett 402: 205-209.
18. Schwable J, Choudhary C, Thiede C, Tickenbrock L, Sargin B, et al. (2005) RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation. Blood 105: 2107-2114.
19. Rollins BJ, Walz A, Baggiolini M, (1991) Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112-1116.
20. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL, (2009) Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 41: 998-1001.
21. Loetscher P, Seitz M, Baggiolini M, Moser B, (1996) Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184: 569-577.
22. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, et al. (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40.
23. Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, et al. (2000) Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 97: 12272-12277.
24. Huang Y, Chen X, Dikov MM, Novitskiy SV, Mosse CA, et al. (2007) Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood 110: 624-631.
25. Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, et al. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111: 5457-5466.
26. Goede V, Brogelli L, Ziche M, Augustin HG, (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82: 765-770.
27. Varney ML, Olsen KJ, Mosley RL, Singh RK, (2005) Paracrine regulation of vascular endothelial growth factor-a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 25: 674-683.
28. Raman D, Baugher PJ, Thu YM, Richmond A, (2007) Role of chemokines in tumor growth. Cancer Lett 256: 137-165.
29. Conti I, Rollins BJ, (2004) CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14: 149-154.
30. Siderovski DP, Blum S, Forsdyke RE, Forsdyke DR, (1990) A set of human putative lymphocyte G0/G1 switch genes includes genes homologous to rodent cytokine and zinc finger protein-encoding genes. DNA Cell Biol 9: 579-587.
31. Siderovski DP, Heximer SP, Forsdyke DR, (1994) A human gene encoding a putative basic helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell Biol 13: 125-147.
32. Chatterjee TK, Fisher RA, (2000) Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs. J Biol Chem 275: 24013-24021.
33. Song L, Zmijewski JW, Jope RS, (2001) RGS2: regulation of expression and nuclear localization. Biochem Biophys Res Commun 283: 102-106.